Nuclear morphology and the biology of cancer cells

EG Fischer - Acta cytologica, 2020 - karger.com
Background: For more than a century, diagnostic pathologists have used morphologic
abnormalities of the nucleus as essential diagnostic features to distinguish benign from …

[HTML][HTML] The role of the transcription factor nuclear factor-kappa B in thyroid autoimmunity and cancer

C Giuliani, I Bucci, G Napolitano - Frontiers in endocrinology, 2018 - frontiersin.org
Nuclear factor-kappa B (NF-κB) is a ubiquitous transcription factor that is involved in
inflammatory and immune responses, as well as in regulation of expression of many other …

Long-term endocrine and metabolic consequences of cancer treatment: a systematic review

J Gebauer, C Higham, T Langer, C Denzer… - Endocrine …, 2019 - academic.oup.com
The number of patients surviving≥ 5 years after initial cancer diagnosis has significantly
increased during the last decades due to considerable improvements in the treatment of …

[HTML][HTML] Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization

YH Chu, LJ Wirth, AA Farahani, V Nosé, WC Faquin… - Modern Pathology, 2020 - Elsevier
The discovery of actionable kinase gene rearrangements has revolutionized the therapeutic
landscape of thyroid carcinomas. Unsolved challenges include histopathologic recognition …

[HTML][HTML] Molecular alterations in thyroid cancer: from bench to clinical practice

E Tirrò, F Martorana, C Romano, SR Vitale, G Motta… - Genes, 2019 - mdpi.com
Thyroid cancer comprises different clinical and histological entities. Whereas differentiated
(DTCs) malignancies are sensitive to radioiodine therapy, anaplastic (ATCs) and medullary …

Molecular alterations in thyroid carcinoma

MRH Al Rasheed, B Xu - Surgical pathology clinics, 2019 - surgpath.theclinics.com
Thyroid carcinoma is the most common cancer in the endocrine system. Recent advances,
using next-generation sequencing, have shed light on the molecular pathogenesis of thyroid …

[HTML][HTML] Molecular markers guiding thyroid cancer management

C Nylén, R Mechera, I Maréchal-Ross, V Tsang… - Cancers, 2020 - mdpi.com
The incidence of thyroid cancer is rapidly increasing, mostly due to the overdiagnosis and
overtreatment of differentiated thyroid cancer (TC). The increasing use of potent preclinical …

Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next‐generation sequencing

H Duan, Y Li, P Hu, J Gao, J Ying, W Xu… - …, 2019 - Wiley Online Library
Aims To characterise the mutational profiles of poorly differentiated thyroid carcinoma
(PDTC) and anaplastic thyroid carcinoma (ATC) and to identify markers with potential …

[HTML][HTML] Molecular diagnostic of solid tumor using a next generation sequencing custom-designed multi-gene panel

D de Biase, G Acquaviva, M Visani, V Sanza… - Diagnostics, 2020 - mdpi.com
Next generation sequencing (NGS) allows parallel sequencing of multiple genes at a very
high depth of coverage. The need to analyze a variety of targets for diagnostic/prognostic …

Lymphocyte-monocyte ratio significantly predicts recurrence in papillary thyroid cancer

M Yokota, H Katoh, H Nishimiya, M Kikuchi… - Journal of Surgical …, 2020 - Elsevier
Background A growing body of evidences shows that systemic inflammatory responses are
involved in patient prognosis in multiple cancers. Combinations of peripheral leukocyte …